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Editorial Comment
Coronary Artery Bypass Surgery
to Prolong Life?: Less Anatomy/
More Physiology*
GARY D. PLOTNICK, MD, FACC
Baltimore. Maryland
"A rose is a rose " (l) but "triple vessel disease is not
triple vessel disease " Patients with multivessel disease
do not constitute a homogeneous population. Clinical de-
cision making based only on the number of vessels with
high grade obstructive lesions is a one-dimensional approach
to a multidimensional problem.
Over the last decade, many clinicians have recommended
coronary artery bypass surgery to their patients predomi-
nantly on the basis of the angiographic finding of multivessel
coronary artery disease. The more extensive the coronary
artery disease and the more severe the narrowings, the more
urgent has been the push to surgery. The basis for this
approach can be found in the results of multiple "natural
history" studies which have demonstrated that the prognosis
for groups of patients is correlated with the anatomic extent
of the coronary artery disease (2-5). In addition, numerous
randomized and nonrandomized trials have demonstrated
that groups of patients with extensive coronary artery disease
survive longer when treated surgically than when treated
medically (6-11).
Grouping patients according to the anatomic extent of
the disease (that is, single, double, triple or left main vessel
disease) is simple and has been useful for statistical com-
parisons, but it is now clear that this classification is too
restrictive and does not take into account individual ana-
tomic variations or the physiologic importance of the le-
sions. Attempts at defining anatomic subgroups based on
the degree of obstruction (12) or on the amount of myo-
cardium at risk (jeopardy score) (13,14) have been proposed
but have not yet found wide acceptance. Qualitative (15)
and quantitative (16-19) analyses of the angiographic ap-
pearance of the coronary artery lesions have only recently
been attempted. Errors in estimating the significance of
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coronary artery narrowings as judged by coronary arteri-
ography are well recognized (20).
Functional evaluation (in the form of exercise testing)
has found widespread use in an attempt to determine the
physiologic importance of the anatomic lesion. Using stan-
dard exercise modalities (electrocardiographic, thallium and
radionuclide angiographic stress testing), patients who de-
velop ischemia in a large area of myocardium with minimal
stress appear to be at highest risk for mortality during follow-
up (21,22). Recent reports demonstrate that mortality cor-
relates better with the total amount of myocardium rendered
ischemic during exercise testing than with the number of
obstructed coronary arteries demonstrated angiographically
(23-25).
Identifying patients with improved survival aftersur-
gery. Analysis of three large prospective trials (the Veterans
Administration Cooperative Study of Stable Angina (26),
the European Coronary Surgery Study (27) and now the
Collaborative Study of Coronary Artery Surgery (CASS»
(28.29) documents the value of noninvasive predictors of
risk in identifying patients who are most likely to have life
prolonged with coronary artery bypass surgery. These non-
invasive predictors appear to be more important than the
anatomic extent of disease in risk stratifying and in iden-
tifying the potential benefit of surgery. In the Veterans
Administration study, the benefit of surgery was evaluated
with the patients categorized into high, mid and low risk
terciles based on four easily obtained clinical predictors of
risk: ST segment depression on the baseline rest electro-
cardiogram, a history of myocardial infarction, a history of
hypertension and New York Heart Association functional
class III or IV (26). Five year survival in the surgical and
medical randomized cohorts was 82 versus 64% respectively
(p < 0.01) in the high risk tercile, 81 versus 79% (p =
NS) in the mid risk tercile and 82% versus 93% (p < 0.01)
in the low risk tercile. Thus, in this study surgical therapy
improved the survival rate for the high risk group whereas
medical therapy appeared better for the low risk group.
These significant differences in the high and low risk terciles
remained unchanged after adjustment was made for the num-
ber of diseased vessels and the status of the left ventricle.
Medically treated patients with triple vessel disease who
were in the low risk group had an II % 5 year mortality rate
whereas similarly treated patients with triple vessel disease
who were in the high risk group had a 42% 5 year mortality
rate.
Independent noninvasive clinical predictors ofrisk in the
European Coronary Surgery Study include the presence of
ST-T abnormalities or evidence of a previous myocardial
infarction on the baseline electrocardiogram, a history of
intermittent claudication, increasing age and the develop-
ment of 1.5 mm or greater ST segment depression during
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exercise (27). Patients with few risk factors had a low 5
year mortality rate whereas patients with multiple risk fac-
tors had an extremely high mortality rate. For example, for
a 50 year old man with triple vessel coronary artery disease
the estimated 5 year mortality rate varied from 4% in the
absence of these factors to 60% in their presence. There
appeared to be little or no decrease in mortality with surgical
therapy in patients with few or no risk factors, whereas
mortality decreased significantly with surgical therapy in
patients with multiple risk factors.
Early reports from the most recent of these large pro-
spective studies. the CASSo were widely touted as showing
no advantage for surgical treatment over medical treatment
in the select group of patients included in the randomized
cohort (30). Reports are now emerging of subgroup analysis
in which surgical therapy appears clearly superior to medical
therapy. Despite the statistical arguments against retrospec-
tive subgroup analysis, these reports are of interest. Al-
though a previous report (28) evaluating the smaller ran-
domized population of the CASS failed to show differences
in survival dependent on the final exercise stage achieved
or the degree of ST segment depression, the presence of
exercise-induced angina did identify patients who survived
longer when assigned to surgical therapy. This advantage
was observed primarily in the subset of patients with triple
vessel disease and impaired left ventricular function.
ThepresentCASS report. In this issue of lACC Weiner
and associates (29) report observations on the large, well
studied patient population contained within the CASS reg-
istry. Their study suggests 1) that by using physiologic
(exercise) testing, one can identify high and low risk groups
among patients with triple vessel disease, and 2) that the
high risk group of patients with triple vessel disease will
have improved survival with surgery whereas the low risk
group will not. Among patients with triple vessel disease
who fit into a high risk group (developing 2: I mm ST
segment depression in stage I of a Bruce protocol), the 7
year survival rate was 81% for the 278 surgically treated
patients and 58% for the 120 medically treated patients
(p < 0.0001). Among patients with triple vessel disease
who fit into a low risk group (exercising into stage 3 or
greater without ischemic ST segment depression) the sur-
gical cohort did not survive longer than the medical cohort.
The major strength of this study is the large number of
registry patients who have been studied in detail and fol-
lowed up. Unfortunately, the study's retrospective analysis
of a nonrandomized patient population and lack of com-
parability between the medically and surgically treated groups
make absolute interpretation of both the positive and neg-
ative results somewhat difficult. Despite these problems,
the observations described are of considerable interest.
A clinical extrapolation from this study is that for most
patients physiologic testing may precede arteriographic
evaluation and only patients who are at high risk need to
have definition of their anatomy. Patients in stable condition
at low risk may continue on medical therapy, and deter-
mination of their underlying anatomy is not necessary until
serial noninvasive testing suggests a change in risk status
or symptoms dictate. Even among those patients with known
arteriographically documented triple vessel disease, a sur-
gical approach to prolong life could be reserved for those
who fall into a physiologic "high risk" subgroup. It is my
prejudice that similar results may be present in patients with
double or even single vessel disease but lack of adequate
numbers in each of these subgroups in this study may have
precluded this finding.
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